周四，由刘洋领导的Morgan Stanley分析师团队将涂鸦智能（NYSE:TUYA）的目标股价从3.00美元上调至4.20美元，同时维持"增持"评级。分析师团队表示，此次调整基于公司近期表现和增长潜力。根据InvestingPro数据显示，涂鸦智能在过去六个月内实现了133%的显著回报，同时保持着"优秀"的整体财务健康评分。

周四，Morgan Stanley分析师Bruno Montanari将在纽约证券交易所交易的Petrobras股票（股票代码NYSE:PBR）的目标价从此前的$19.50下调至$19.00。尽管作出了这一调整，但该公司仍维持对该股票的增持评级。根据InvestingPro数据显示，Petrobras保持着"优秀"的财务健康评分3.18，分析师目标价区间为$15.00至$19.50。

20:40【映恩生物向港交所提交上市申请】据港交所文件，映恩生物向港交所提交上市申请，联席保荐人为摩根士丹利（Morgan Stanley）、杰富瑞（Jefferies）、中信证券。

Morgan Stanley’s Swiss unit was fined 1 million Swiss francs ($1.1 million) for failing to prevent the laundering of millions ...

The Swiss attorney general's office said on Thursday it had imposed a $1 million fine on Morgan Stanley's Swiss operations ...

SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that management will ...

Morgan Stanley's Jonathan Garner says he's bullish on Indian equities as valuations rebound, and expands on the 'China vs ...

Morgan Stanley also drew scrutiny previously for fielding an all-white, all-male slate of candidates to succeed former CEO ...

In a report released today, Melinda Baxter from Morgan Stanley maintained a Buy rating on IDP Education Ltd. (03F – Research Report), with a ...

Block, Inc. (XYZ) received an upgrade to Equal Weight by Morgan Stanley analysts, citing the fintech company's valuation is ...

Investors are anxiously waiting for Nvidia’s (NVDA) fourth-quarter earnings report, which may provide a much-needed boost to ...

智通财经APP获悉，映恩生物(Duality Biotherapeutics, Inc.)于2024年8月26日所递交的港股招股书满6个月，于2025年2月26日失效，递表时Morgan Stanley、Jefferies、CITIC ...